Resverlogix Provides Update on BETonMACE Phase 3 Epigenetics Trial – PM360Resverlogix Provides Update on BETonMACE ...BOSTON, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...
